Meta-analysisindependent cross-checkabstract checked★ key study I-SYS-105 in-depth review

Most sore throats get better on their own

Antibiotics for treatment of sore throat in children and adults.

Overview

Spinks A et al.. Cochrane Database Syst Rev 2021 · PMID 34881426 · DOI 10.1002/14651858.CD000023.pub5

82% of people without antibiotics were symptom-free within a week; antibiotics still prevented some complications.

Does the study support the specific claim? Partly · Methodological quality: high

Study explained simply

What did the researchers want to find out?: Antibiotics for sore throat.
How was the study done?: Cochrane review.
How many people, animals or samples were studied?: 29 trials.
What was actually found?: Most heal alone; antibiotics help modestly.
How large was the observed effect?: RR 0.50 at 1 week.
What do the results mean in everyday life?: Self-healing is real for minor illness, not for everything.
What are the study's limitations?: Old trials.
What does it say about Elawady's specific claim?: Supports the kernel, not 'unlimited' healing.
Do the results apply to Germany and Europe?: High.
What can explicitly not be concluded from this study?: Serious diseases.

Authors: Spinks A et al.
Journal: Cochrane Database Syst Rev
Year: 2021
Identifier: PMID 34881426 DOI 10.1002/14651858.CD000023.pub5
Verification: verified – PubMed efetch 2026-10-26 + Crossref
Retracted: no
Corrections: none
Extent checked: abstract only
Conflicts of interest and funding: Author declarations in record (one author on Therapeutic Guidelines board)

Effects of antibiotics vs placebo/no treatment for sore throat

Study design: Meta-analysis – Cochrane systematic review and meta-analysis of RCTs
Population: Children and adults with sore throat
Country: International
Period: Searches to April 2021
Sample size: 29 trials, 15,337 cases
Inclusion and exclusion criteria: RCTs/quasi-RCTs with placebo or no-treatment control

Results: 82% of placebo/no-treatment participants were symptom-free by one week. Antibiotics reduced sore throat at day 3 (RR 0.70, 0.60-0.80) and week 1 (RR 0.50, 0.34-0.75; NNTB 18), reduced acute otitis media (Peto OR 0.21) and quinsy (Peto OR 0.16) and acute rheumatic fever (Peto OR 0.36, moderate certainty).
Absolute risks: NNTB <6 at day 3; 18 at week 1
Authors' conclusion: Antibiotics probably reduce symptoms and some complications; benefits are modest and must be weighed against resistance.

Implied control risk at week 1 ~11% from NNT 18 and RR 0.50 (recalculated).

Fair example of the correct kernel: many acute illnesses resolve on their own; but treatment still prevents some serious complications.

High.

Mixed: supports self-limitation of minor illness, not unlimited self-healing.

Multidimensional assessment
Multidimensional assessment
Authenticity of the source	verified
Methodological quality	high
Risk of bias	low
Precision of results	high
Directness	indirect
Reproducibility	replicated
Consistency with the overall evidence	consistent
Regional transferability	high
Adequacy of the interpretation (by the archive)	not applicable